Arecor Therapeutics
Arecor is a revenue-generating clinical-stage drug developer. Its proprietary Arestat formulation platforms are the basis of an in-house and partnered pipeline of enhanced products with lower development risks and less onerous regulatory approvals.
View MoreAcquisition of Tetris Pharma and £6m equity raise
Arecor Therapeutics | Lighthouse | 01 August 2022
View MoreAmbitious, focussed, and delivering on its promise
Arecor Therapeutics | Update | 25 April 2022
View MoreFormulation expertise exemplified in diabetes
Arecor Therapeutics | Update | 20 January 2021
View MoreH121 results underline quality of management execution
Arecor Therapeutics | Lighthouse | 23 September 2021
View MoreAT278 Phase I delivers better than expected results
Arecor Therapeutics | Lighthouse | 20 September 2021
View More